Preloader

Myeloproliferative Neoplasms (MPN) Panel

Myeloproliferative Neoplasms (MPNs) are a group of hematological disorders characterized by the abnormal proliferation of blood-forming cells in the bone marrow. These disorders may lead to increased production of red blood cells, white blood cells, or platelets, disrupting the balance of blood cells. Genetic changes, such as alterations in the JAK2 gene, and specific chromosomal rearrangements may play a role in the development of MPNs. Identifying these genetic and chromosomal abnormalities can help classify the disease and distinguish it from other hematological disorders.

MPN treatment is planned according to the disease subtype, risk level, symptoms, and the patient’s overall health. Treatment options may include medications that control blood cell production, targeted therapies, and supportive care when needed. Genetic and chromosomal analyses can help characterize the disease and support clinical decision-making.

Genetic Alterations Method Sample Type
CHIC2 deletion FISH Bone Marrow / Heparinized Blood
FGFR1 (8p12) rearrangement FISH Bone Marrow / Heparinized Blood
PDGFRB (5q33.1) rearrangement FISH Bone Marrow / Heparinized Blood
t(9;22) & variants FISH Bone Marrow / Heparinized Blood
JAK2 (9p24) rearrangement FISH Bone Marrow / Heparinized Blood
(12p13) rearrangement FISH Bone Marrow / Heparinized Blood
Monosomy 7 ve 7q deletion FISH Bone Marrow / Heparinized Blood
Trisomy 8 FISH Bone Marrow / Heparinized Blood

 

//
Our customer support team is here to answer your questions!